[1]
|
Grohe, K., Zeiler, H.-J., Metzger, K.G. and Grohe, K. (1987) 7-Amino-1-Cyclopropyl-4-Oxo-1, 4-Dihydro-Quinoline- and Naphthyridine-3-Carboxylic Acids and Antibacterial Agents Containing These Compounds. US4670444 (A). http://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19870602&DB=EPODOC&locale=en_EP&CC=US&NR=4670444A&KC=A&ND=5
|
[2]
|
Wright, D.H., Brown, G.H., Peterson, M.L. and Rotschafer, J.C. (2000) Application of Fluoroquinolone Pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669-683. http://dx.doi.org/10.1093/jac/46.5.669
|
[3]
|
Fauchier, N. (2013) Med’Vet, le recueil des spécialités à usage vétérinaire. 2014th Edition, Med’com, Paris.
|
[4]
|
Committee for Medicinal Products for Veterinary Use (CVMP) (2007) Public Statement on the Use of (Fluoro) Quinolones in Food-Producing Animals in the European Union: Development of Resistance and Impact on Human and Animal Health.
|
[5]
|
Barbosa, J., Barrón, D., Jiménez-Lozano, E. and Sanz-Nebot, V. (2001) Comparison between Capillary Electrophoresis, Liquid Chromatography, Potentiometric and Spectrophotometric Techniques for Evaluation of pKa Values of Zwitterionic Drugs in Acetonitrile-Water Mixtures. Analytica Chimica Acta, 437, 309-321. http://dx.doi.org/10.1016/S0003-2670(01)00997-7
|
[6]
|
Lizondo, M., Pons, M., Gallardo, M. and Estelrich, J. (1997) Physicochemical Properties of Enrofloxacin. Journal of Pharmaceutical and Biomedical Analysis, 15, 1845-1849. http://dx.doi.org/10.1016/S0731-7085(96)02033-X
|
[7]
|
Lin, C.-E., Deng, Y.-J., Liao, W.-S., Sun, S.-W., Lin, W.-Y. and Chen, C.-C. (2004) Electrophoretic Behavior and pKa Determination of Quinolones with a Piperazinyl Substituent by Capillary Zone Electrophoresis. Journal of Chromatography A, 1051, 283-290. http://dx.doi.org/10.1016/j.chroma.2004.08.069
|
[8]
|
Takács-Novák, K., Józan, M., Hermecz, I. and Szász, G. (1992) Lipophilicity of Antibacterial Fluoroquinolones. International Journal of Pharmaceutics, 79, 89-96. http://dx.doi.org/10.1016/0378-5173(92)90099-N
|
[9]
|
Levine, C., Hiasa, H. and Marians, K.J. (1998) DNA Gyrase and Topoisomerase IV: Biochemical Activities, Physiological Roles during Chromosome Replication, and Drug Sensitivities. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, 1400, 29-43. http://dx.doi.org/10.1016/S0167-4781(98)00126-2
|
[10]
|
Kato, J., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S. and Suzuki, H. (1990) New Topoisomerase Essential for Chromosome Segregation in E. coli. Cell, 63, 393-404. http://dx.doi.org/10.1016/0092-8674(90)90172-B
|
[11]
|
Anselmi, C., Bocchinfuso, G., De Santis, P. and Fuà, M. (1998) A. Scipioni, M. Savino, Statistical Thermodynamic Approach for Evaluating the Writhe Transformations in Circular DNAs. The Journal of Physical Chemistry B, 102, 5704-5714. http://dx.doi.org/10.1021/jp981552v
|
[12]
|
Chong, S., Chen, C., Ge, H. and Xie, X.S. (2014) Mechanism of Transcriptional Bursting in Bacteria. Cell, 158, 314-326. http://dx.doi.org/10.1016/j.cell.2014.05.038
|
[13]
|
Gubaev, A. and Klostermeier, D. (2014) The Mechanism of Negative DNA Supercoiling: A Cascade of DNA-Induced Conformational Changes Prepares Gyrase for Strand Passage. DNA Repair, 16, 23-34. http://dx.doi.org/10.1016/j.dnarep.2014.01.011
|
[14]
|
Horowitz, D.S. and Wang, J.C. (1987) Mapping the Active Site Tyrosine of Escherichia coli DNA Gyrase. The Journal of Biological Chemistry, 262, 5339-5344.
|
[15]
|
Tse, Y.C., Kirkegaard, K. and Wang, J.C. (1980) Covalent Bonds between Protein and DNA. Formation of Phosphotyrosine Linkage between Certain DNA Topoisomerases and DNA. The Journal of Biological Chemistry, 255, 5560-5565.
|
[16]
|
Wang, J.C., (1998) Moving One DNA Double Helix through Another by a Type II DNA Topoisomerase: The Story of a Simple Molecular Machine. Quarterly Reviews of Biophysics, 31, 107-144. http://dx.doi.org/10.1017/S0033583598003424
|
[17]
|
Gellert, M., Mizuuchi, K., O’Dea, M.H. and Nash, H.A. (1976) DNA Gyrase: An Enzyme that Introduces Superhelical Turns into DNA. Proceedings of the National Academy of Sciences of the United States of America, 73, 3872-3876. http://dx.doi.org/10.1073/pnas.73.11.3872
|
[18]
|
Peng, H. and Marians, K.J. (1995) The Interaction of Escherichia coli Topoisomerase IV with DNA. The Journal of Biological Chemistry, 270, 25286-25290. http://dx.doi.org/10.1074/jbc.270.42.25286
|
[19]
|
Peng, H. and Marians, K.J. (1993) Decatenation Activity of Topoisomerase IV during oriC and pBR322 DNA Replication in Vitro. Proceedings of the National Academy of Sciences of the United States of America, 90, 8571-8575. http://dx.doi.org/10.1073/pnas.90.18.8571
|
[20]
|
Zechiedrich, E.L. and Cozzarelli, N.R. (1995) Roles of Topoisomerase IV and DNA Gyrase in DNA Unlinking during Replication in Escherichia coli. Genes & Development, 9, 2859-2869. http://dx.doi.org/10.1101/gad.9.22.2859
|
[21]
|
Danilchanka, O., Pavlenok, M. and Niederweis, M. (2008) Role of Porins for Uptake of Antibiotics by Mycobacterium Smegmatis. Antimicrobial Agents and Chemotherapy, 52, 3127-3134. http://dx.doi.org/10.1128/AAC.00239-08
|
[22]
|
Yamano, Y., Nishikawa, T. and Komatsu, Y. (1999) Outer Membrane Proteins Responsible for the Penetration of β-Lactams and Quinolones in Pseudomonas Aeruginosa. Journal of Antimicrobial Chemotherapy, 26, 175-184. http://dx.doi.org/10.1093/jac/26.2.175
|
[23]
|
Brauser, A., Schroeder, I., Gutsmann, T., Cosentino, C. and Moroni, A., Hansen, U.-P., et al. (2012) Modulation of Enrofloxacin Binding in OmpF by Mg2+ as Revealed by the Analysis of Fast Flickering Single-Porin Current. The Journal of General Physiology, 140, 69-82. http://dx.doi.org/10.1085/jgp.201210776
|
[24]
|
Bryan, L.E. and Bedard, J. (1991) Impermeability to Quinolones in Gram-Positive and Gram-Negative Bacteria. European Journal of Clinical Microbiology & Infectious Diseases, 10, 232-239. http://dx.doi.org/10.1007/BF01966995
|
[25]
|
Bedard, J., Wong, S. and Bryan, L.E. (1987) Accumulation of Enoxacin by Escherichia coli and Bacillus Subtilis. Antimicrobial Agents and Chemotherapy, 31, 1348-1354. http://dx.doi.org/10.1128/AAC.31.9.1348
|
[26]
|
Lambert, P. A. (2002) Cellular Impermeability and Uptake of Biocides and Antibiotics in Gram-Positive Bacteria and Mycobacteria. Journal of Applied Microbiology, 92, 46S-54S. http://dx.doi.org/10.1046/j.1365-2672.92.5s1.7.x
|
[27]
|
Kampranis, S.C. and Maxwell, A. (1998) The DNA Gyrase-Quinolone Complex ATP Hydrolysis and the Mechanism of DNA Cleavage. The Journal of Biological Chemistry, 273, 22615-22626. http://dx.doi.org/10.1074/jbc.273.35.22615
|
[28]
|
Kampranis, S.C. and Maxwell, A. (1998) Conformational Changes in DNA Gyrase Revealed by Limited Proteolysis. The Journal of Biological Chemistry, 273, 22606-22614. http://dx.doi.org/10.1074/jbc.273.35.22606
|
[29]
|
Leo, E., Gould, K.A., Pan, X.-S., Capranico, G., Sanderson, M.R., Palumbo, M., et al. (2005) Novel Symmetric and Asymmetric DNA Scission Determinants for Streptococcus Pneumoniae Topoisomerase IV and Gyrase Are Clustered at the DNA Breakage Site. The Journal of Biological Chemistry, 280, 14252-14263. http://dx.doi.org/10.1074/jbc.M500156200
|
[30]
|
Lockshon, D. and Morris, D.R. (1985) Sites of Reaction of Escherichia coli DNA Gyrase on pBR322 in Vivo as Revealed by Oxolinic Acid-Induced Plasmid Linearization. Journal of Molecular Biology, 181, 63-74. http://dx.doi.org/10.1016/0022-2836(85)90324-9
|
[31]
|
Wentzell, L.M. and Maxwell, A. (2000) The Complex of DNA Gyrase and Quinolone Drugs on DNA Forms a Barrier to the T7 DNA Polymerase Replication Complex. Journal of Molecular Biology, 304, 779-791. http://dx.doi.org/10.1006/jmbi.2000.4266
|
[32]
|
Kelley W.L. (2006) Lex Marks the Spot: The Virulent Side of SOS and a Closer Look at the LexA Regulon. Molecular Microbiology, 62, 1228-1238. http://dx.doi.org/10.1111/j.1365-2958.2006.05444.x
|
[33]
|
Malik, M., Zhao, X. and Drlica (2006) K., Lethal Fragmentation of Bacterial Chromosomes Mediated by DNA Gyrase and Quinolones. Molecular Microbiology, 61, 810-825. http://dx.doi.org/10.1111/j.1365-2958.2006.05275.x
|
[34]
|
Maguin, E., Lutkenhaus, J. and D’Ari, R. (1986) Reversibility of SOS-Associated Division Inhibition in Escherichia coli. Journal of Bacteriology, 166, 733-738.
|
[35]
|
Drlica, K., Malik, M., Kerns, R.J., Zhao, X. (2008) Quinolone-Mediated Bacterial Death, Antimicrob. Antimicrobial Agents and Chemotherapy. 52, 385-392. http://dx.doi.org/10.1128/AAC.01617-06
|
[36]
|
Gocke, E. (1991) Mechanism of Quinolone Mutagenicity in Bacteria. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 248, 135-143. http://dx.doi.org/10.1016/0027-5107(91)90095-6
|
[37]
|
Cohn, L.A., Gary, A.T., Fales, W.H. and Madsen, R.W. (2003) Trends in Fluoroquinolone Resistance of Bacteria Isolated from Canine Urinary Tracts. Journal of Veterinary Diagnostic Investigation, 15, 338-343. http://dx.doi.org/10.1177/104063870301500406
|
[38]
|
Cummings, K.J., Aprea, V.A. and Altier, C. (2014) Antimicrobial Resistance Trends among Escherichia coli Isolates Obtained from Dairy Cattle in the Northeastern United States, 2004-2011. Foodborne Pathogens and Disease, 11, 61-67. http://dx.doi.org/10.1089/fpd.2013.1605
|
[39]
|
Pereira, R.V., Siler, J.D., Ng, J.C., Davis, M.A., Grohn, Y.T. and Warnick, L.D. (2014) Effect of On-Farm Use of Antimicrobial Drugs on Resistance in Fecal Escherichia coli of Pre-weaned Dairy Calves. Journal of Dairy Science, 41, 92-99. http://dx.doi.org/10.3168/jds.2014-8521
|
[40]
|
Ruiz, J., Pons, M.J. and Gomes, C. (2012) Transferable Mechanisms of Quinolone Resistance. International Journal of Antimicrobial Agents, 40, 196-203. http://dx.doi.org/10.1016/j.ijantimicag.2012.02.011
|
[41]
|
Drlica, K. and Zhao, X. (1997) DNA Gyrase, Topoisomerase IV, and the 4-Quinolones. Microbiology and Molecular Biology Reviews, 61, 377-392.
|
[42]
|
Yoshida, H., Bogaki, M., Nakamura, M. and Nakamura, S. (1990) Quinolone Resistance-Determining Region in the DNA Gyrase gyrA Gene of Escherichia coli. Antimicrobial Agents and Chemotherapy, 34, 1271-1272. http://dx.doi.org/10.1128/AAC.34.6.1271
|
[43]
|
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L.M. and Nakamura, S. (1991) Quinolone Resistance-Determining region in the DNA Gyrase gyrA Gene of Escherichia coli. Antimicrobial Agents and Chemotherapy, 35, 1647-1650. http://dx.doi.org/10.1128/AAC.35.8.1647
|
[44]
|
Nakamura, S., Nakamura, M., Kojima, T. and Yoshida, H. (1989) gyrA and gyrB Mutations in Quinolone-Resistant Strains of Escherichia coli. Antimicrobial Agents and Chemotherapy, 33, 254-255. http://dx.doi.org/10.1128/AAC.33.2.254
|
[45]
|
Hopkins, K.L., Davies, R.H. and Threlfall, E.J. (2005) Mechanisms of Quinolone Resistance in Escherichia coli and Salmonella: Recent Developments. International Journal of Antimicrobial Agents, 25, 358-373. http://dx.doi.org/10.1016/j.ijantimicag.2005.02.006
|
[46]
|
Tran, J.H., Jacoby, G.A. and Hooper, D.C. (2005) Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase. Antimicrobial Agents and Chemotherapy, 49, 118-125. http://dx.doi.org/10.1128/AAC.49.1.118-125.2005
|
[47]
|
Vetting, M.W., Hegde, S.S., Wang, M., Jacoby, G.A., Hooper, D.C. and Blanchard, J.S. (2011) Structure of QnrB1, a Plasmid-Mediated Fluoroquinolone Resistance Factor. The Journal of Biological Chemistry, 286, 25265-25273. http://dx.doi.org/10.1074/jbc.M111.226936
|
[48]
|
Dalhoff, A., Matutat, S. and Ullmann, U. (1995) Effect of Quinolones against Slowly Growing Bacteria. Chemotherapy, 41, 92-99. http://dx.doi.org/10.1159/000239329
|
[49]
|
George, A.M. and Levy, S.B. (1983) Amplifiable Resistance to Tetracycline, Chloramphenicol, and Other Antibiotics in Escherichia coli: Involvement of a Non-Plasmid-Determined Efflux of Tetracycline. Journal of Bacteriology, 155, 531-540.
|
[50]
|
Goldman, J.D., White, D.G. and Levy, S.B. (1996) Multiple Antibiotic Resistance (Mar) Locus Protects Escherichia coli from Rapid Cell Killing by Fluoroquinolones. Antimicrobial Agents and Chemotherapy, 40, 1266-1269.
|
[51]
|
Cohen, S.P., McMurry, L.M. and Levy, S.B. (1988) MarA Locus Causes Decreased Expression of OmpF Porin in Multiple-Antibiotic-Resistant (Mar) Mutants of Escherichia coli. Journal of Bacteriology, 170, 5416-5422.
|
[52]
|
Tavío, M. del M., Vila, J., Ruiz, J., Ruiz, J., Martín-Sánchez, A.M. and de Anta, M.T.J. (1999) Mechanisms Involved in the Development of Resistance to Fluoroquinolones in Escherichia coli Isolates. Journal of Antimicrobial Chemotherapy, 44, 735-742. http://dx.doi.org/10.1093/jac/44.6.735
|
[53]
|
Martínez-Martínez, L., Pascual, A. and Jacoby, G.A. (1998) Quinolone Resistance from a Transferable Plasmid. The Lancet, 351, 797-799. http://dx.doi.org/10.1016/S0140-6736(97)07322-4
|
[54]
|
Blondeau, J.M., Zhao, X., Hansen, G. and Drlica, K. (2001) Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus Pneumoniae. An-timicrobial Agents and Chemotherapy, 45, 433-438. http://dx.doi.org/10.1128/AAC.45.2.433-438.2001
|
[55]
|
Nielsen, P. and Gyrd-Hansen, N. (1997) Bioavailability of Enrofloxacin after Oral Administration to Fed and Fasted Pigs. Pharmacology & Pharmaceutical Medicine, 80, 246-250. http://dx.doi.org/10.1111/j.1600-0773.1997.tb01967.x
|
[56]
|
Vancutsem, P., Babish, J. and Schwark, W. (1990) The Fluoroquinolone Antimicrobials: Structure, Antimicrobial Activity, Pharmacokinetics, Clinical Use in Domestic Animals and Toxicity. The Cornell Veterinarian, 80, 173-186.
|
[57]
|
Steinman, A., Britzi, M., Levi, O., Lavy, E., Lichter, A. and Soback, S. (2006) Lack of Effect of Diet on the Pharmacokinetics of Enrofloxacin in Horses. Journal of Veterinary Pharmacology and Therapeutics, 29, 67-70. http://dx.doi.org/10.1111/j.1365-2885.2006.00717.x
|
[58]
|
Ziólkowski, H., Jaroszewski, J.J., Maslanka, T., Grabowski, T., Katolik, K., Paweska, J., et al. (2014) Influence of Oral Co-Administration of a Preparation Containing Calcium and Magnesium and Food on Enrofloxacin Pharmacokinetics. Research in Veterinary Science, 97, 99-104. http://dx.doi.org/10.1016/j.rvsc.2014.05.005
|
[59]
|
Simon, Z., Katja, B., Darko, U., Marjan, V. and Albin, K. (2010) Metal Cation–Fluoroquinolone Complexes Do Not Permeate through the Intestinal Absorption Barrier. Journal of Pharmaceutical and Biomedical Analysis, 53, 655-659. http://dx.doi.org/10.1016/j.jpba.2010.05.021
|
[60]
|
Sumano, L.H., Gutierrez, O.L., Aguilera, R., Rosiles, M.R., Bernard, B.M.J., Gracia, M.J. (2004) Influence of Hard Water on the Bioavailability of Enrofloxacin in Broilers. Poultry Science, 83, 726-731. http://dx.doi.org/10.1093/ps/83.5.726
|
[61]
|
Coulet, M., Morello, C., Cox, P. and Lohuis, J. (2005) Pharmacoki-netics of Ibafloxacin in Healthy Cats. Journal of Veterinary Pharmacology and Therapeutics, 28, 37-44. http://dx.doi.org/10.1111/j.1365-2885.2004.00623.x
|
[62]
|
Dautrey, S., Felice, K., Petiet, A., Lacour, B., Carbon, C. and Farinotti, R. (1999) Active Intestinal Elimination of Ciprofloxacin in Rats: Modulation by Different Substrates, British Journal of Pharmacology, 127, 1728-1734. http://dx.doi.org/10.1038/sj.bjp.0702703
|
[63]
|
Tyczkowska, K., Hedeen, K.M., Aucoin, D.P. and Aronson, A.L. (1989) High-Performance Liquid Chromatographic Method for the Simultaneous Determination of Enrofloxacin and Its Primary Metabolite Ciprofloxacin in Canine Serum and Prostatic Tissue. Journal of Chromatography B: Biomedical Sciences and Applications, 493, 337-346. http://dx.doi.org/10.1016/S0378-4347(00)82739-5
|
[64]
|
Riviere, J.E., and Papich, M.G. (2013) Veterinary Pharmacology and Therapeutics. John Wiley & Sons, Hoboken, 993.
|
[65]
|
Cester, C.C. and Toutain, P.L. (1997) A Comprehensive Model for Enrofloxacin to Ciprofloxacin Transformation and Disposition in Dog. Journal of Pharmaceutical Sciences, 86, 1148-1155. http://dx.doi.org/10.1021/js9603461
|
[66]
|
Küng, K., Riond, J.-L. and Wanner, M. (1993) Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin after Intravenous and Oral Administration of Enrofloxacin in Dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462-468. http://dx.doi.org/10.1111/j.1365-2885.1993.tb00212.x
|
[67]
|
Pasquali, F. and Manfreda, G. (2007) Mutant Prevention Concentration of Ciprofloxacin and Enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas Aeruginosa. Veterinary Microbiology, 119, 304-310. http://dx.doi.org/10.1016/j.vetmic.2006.08.018
|
[68]
|
Ogino, T., Mizuno, Y., Ogata, T. and Takahashi, Y. (2005) Pharmacokinetic Interactions of Flunixin Meglumine and Enrofloxacin in Dogs. American Journal of Veterinary Research, 66, 1209-1213. http://dx.doi.org/10.2460/ajvr.2005.66.1209
|
[69]
|
Nouws, J.F.M., Mevius, D.J., Vree, T.B., Baars, A.M. amd Laurensen, J. (1988) Pharmacokinetics, Renal Clearance and Metabolism of Ciprofloxacin Following Intravenous and Oral Administration to Calves and Pigs. Veterinary Quarterly, 10, 156-163. http://dx.doi.org/10.1080/01652176.1988.9694165
|
[70]
|
Hwang, Y.H., Kim, M.S., Song, I.B., Lim, J.H., Park, B.K. and Yun, H.I. (2009) Altered Pharmacokinetics of Enrofloxacin in Experimental Models of Hepatic and Renal Impairment. Veterinary Research Communications, 33, 481-487. http://dx.doi.org/10.1007/s11259-008-9195-y
|
[71]
|
Rao, G.S., Ramesh, S., Ahmad, A.H., Tripathi, H.C., Sharma, L.D. and Malik, J.K. (2002) Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Goats Given Enrofloxacin Alone and in Combination with Probenecid. The Veterinary Journal, 163, 85-93. http://dx.doi.org/10.1053/tvjl.2001.0594
|
[72]
|
Neuman, M. (1986) Comparative Pharmacokinetic Parameters of New Systemic Fluoroquinolones. International Journal of Clinical Pharmacology Research, 7, 173-179.
|
[73]
|
Martinez, M., McDermott, P. and Walker, R. (2006) Pharmacology of the Fluoroquinolones: A Perspective for the Use in Domestic Animals. The Veterinary Journal, 172, 10-28. http://dx.doi.org/10.1016/j.tvjl.2005.07.010
|
[74]
|
Wiuff, C., Lykkesfeldt, J., Aarestrup, F.M. and Svendsen, O. (2002) Distribution of Enrofloxacin in Intestinal Tissue and Contents of Healthy Pigs after Oral and Intramuscular Administrations. Journal of Veterinary Pharmacology and Therapeutics, 25, 335-342. http://dx.doi.org/10.1046/j.1365-2885.2002.00430.x
|
[75]
|
Idowu, O.R., Peggins, J.O., Cullison, R. and von Bredow, J. (2010) Comparative Pharmacokinetics of Enrofloxacin and Ciprofloxacin in Lactating Dairy Cows and Beef Steers Following Intravenous Administration of Enrofloxacin. Research in Veterinary Science, 89, 230-235. http://dx.doi.org/10.1016/j.rvsc.2009.12.019
|
[76]
|
Yu, F., Yu, S., Yu, L., Li, Y., Wu, Y., Zhang, H., et al. (2014) Determination of Residual Enrofloxacin in Food Samples by a Sensitive Method of Chemiluminescence Enzyme Immunoassay. Food Chemistry, 149, 71-75. http://dx.doi.org/10.1016/j.foodchem.2013.10.024
|
[77]
|
Cinquina, A.L., Roberti, P., Giannetti, L., Longo, F., Draisci, R., Fagiolo, A., et al. (2003) Determination of Enrofloxacin and Its Metabolite Ciprofloxacin in Goat Milk by High-Performance Liquid Chromatography with Diode-Array Detection: Optimization and Validation. Journal of Chromatography A, 987, 221-226. http://dx.doi.org/10.1016/S0021-9673(02)01800-9
|
[78]
|
González, C., Moreno, L., Fumuso, E., García, J., Rivulgo, M., Confalonieri, A., et al. (2009) Enrofloxacin-Based Therapeutic Strategy for the Prevention of Endometritis in Susceptible Mares. Journal of Veterinary Pharmacology and Therapeutics, 33, 287-294. http://dx.doi.org/10.1111/j.1365-2885.2009.01135.x
|
[79]
|
Sapkota, A., Sapkota, A.R., Kucharski, M., Burke, J., McKenzie, S., Walker, P., et al. (2008) Aquaculture Practices and Potential Human Health Risks: Current Knowledge and Future Priorities. Environment International, 34, 1215-1226. http://dx.doi.org/10.1016/j.envint.2008.04.009
|
[80]
|
Sarkozy, G. (2001) Quinolones: A Class of Antimicrobial Agents. Veterinární Medicína (Praha), 46, 257-274.
|
[81]
|
Aral, F., Karaçal, F. and Baba, F. (2008) The Effect of Enrofloxacin on Sperm Quality in Male Mice. Research in Veterinary Science, 84, 95-99. http://dx.doi.org/10.1016/j.rvsc.2007.04.007
|
[82]
|
Westropp, J.L., Sykes, J.E., Irom, S., Daniels, J.B., Smith, A., Keil, D., et al. (2012) Evaluation of the Efficacy and Safety of High Dose Short Duration Enrofloxacin Treatment Regimen for Uncomplicated Urinary Tract Infections in Dogs. Journal of Veterinary Internal Medicine, 26, 506-512. http://dx.doi.org/10.1111/j.1939-1676.2012.00914.x
|
[83]
|
Hayem, G., Petit, P.X., Levacher, M., Gaudin, C., Kahn, M.F. and Pocidalo, J.J. (1994) Cytofluorometric Analysis of Chondrotoxicity of Fluoroquinolone Antimicrobial Agents. Antimicrobial Agents and Chemotherapy, 38, 243-247. http://dx.doi.org/10.1128/AAC.38.2.243
|
[84]
|
Lim, S., Hossain, M.A., Park, J., Choi, S.H. and Kim, G. (2008) The Effects of Enrofloxacin on Canine Tendon Cells and Chondrocytes Proliferation in Vitro. Veterinary Research Communications, 32, 243-253. http://dx.doi.org/10.1007/s11259-007-9024-8
|
[85]
|
Maslanka, T., Jaroszewski, J.J., Mikolajczyk, A. and Rotkiewicz, T. (2009) Effect of Increasing Doses of Enrofloxacin on Chicken Articular Cartilage. Polish Journal of Veterinary Sciences, 12, 21-33.
|
[86]
|
Bertone, A.L., Tremaine, W.H., Macoris, D.G., Simmons, E.J., Ewert, K.M., Herr, L.G., et al. (2000) Effect of Long-Term Administration of an Injectable Enrofloxacin Solution on Physical and Musculoskeletal Variables in Adult Horses. Journal of the American Veterinary Medical Association, 217, 1514-1521. http://dx.doi.org/10.2460/javma.2000.217.1514
|
[87]
|
Al-Nazawi, M.H. (2008) Effects of Enrofloxacin and Marbofloxacin Administration on Some Fertility Parameters of Male Chicken. Journal of Taibah University for Science, 1, 1-4. http://dx.doi.org/10.1016/S1658-3655(12)60027-2
|
[88]
|
Rodriguez, J.S., Han, S., Nielsen, S., Pearson, L.K., Gay, J.M. and Tibary, A. (2012) Consequences of Intrauterine Enrofloxacin Infusion on Mare Endometrium. Journal of Equine Veterinary Science, 32, 106-111. http://dx.doi.org/10.1016/j.jevs.2011.08.003
|
[89]
|
Gelatt, K.N., Van Der Woerdt, A., Ketring, K.L., Andrew, S.E., Brooks, D.E., Biros, D.J., et al. (2001) Enrofloxacin-Associated Retinal Degeneration in Cats. Veterinary Ophthalmology, 4, 99-106. http://dx.doi.org/10.1046/j.1463-5224.2001.00182.x
|
[90]
|
Giuliano, E.A. and van der Woerdt, A. (1999) Feline Retinal Degeneration: Clinical Experience and New Findings (1994-1997). Jaaha-American Animal Hospital Association, 35, 511-514. http://dx.doi.org/10.5326/15473317-35-6-511
|
[91]
|
Yan, H., Tian, M. and Row, K.H. (2008) Determination of Enrofloxacin and Ciprofloxacin in Milk Using Molecularly Imprinted Solid-Phase Extraction. Journal of Separation Science, 31, 3015-3020. http://dx.doi.org/10.1002/jssc.200800315
|
[92]
|
Ahn, Y., Linder, S.W., Veach, B.T., Steve Yan, S., Haydée Fernández, A., Pineiro, S.A., et al. (2012) In Vitro Enrofloxacin Binding in Human Fecal Slurries. Regulatory Toxicology and Pharmacology, 62, 74-84. http://dx.doi.org/10.1016/j.yrtph.2011.11.013
|
[93]
|
Committee for Medicinal Products for Veterinary Use (CVMP) (2002) Enrofloxacin, Summary Report (5).
|
[94]
|
Committee for Medicinal Products for Veterinary Use (CVMP) (1998) Enrofloxacin, Summary Report (2).
|
[95]
|
Dunnett, M., Richardson, D.W. and Lees, P. (2004) Detection of Enrofloxacin and Its Metabolite Ciprofloxacin in Equine Hair. Research in Veterinary Science, 77, 143-151. http://dx.doi.org/10.1016/j.rvsc.2004.03.004
|
[96]
|
Gorla, N., Chiostri, E., Ugnia, L., Weyers, A., Giacomelli, N., Davicino, R., et al. (1997) HPLC Residues of Enrofloxacin and Ciprofloxacin in Eggs of Laying Hens. International Journal of Antimicrobial Agents, 8, 253-256. http://dx.doi.org/10.1016/S0924-8579(97)00018-6
|
[97]
|
Yatsukawa, Y., Ito, H., Matsuda, T., Nakamura, M., Watai, M. and Fujita, K. (2011) Determination of Residual Fluoroquinolones in Honey by Liquid Chromatography Using Metal Chelate Affinity Chromatography. Journal of AOAC International, 94, 1319-1327.
|
[98]
|
Boxall, A., Kolpin, D., Holling-Sorensen, B. and Tolls, J. (2003) Are Veterinary Medicines Causing Environmental Risks? Environmental Science & Technology, 15, 286A-294A.
|
[99]
|
Van Doorslaer, X., Dewulf, J., Van Langenhove, H. and Demeestere, K. (2014) Fluoroquinolone Antibiotics: An Emerging Class of Environmental Micropollutants. Science of the Total Environment, 500-501, 250-269. http://dx.doi.org/10.1016/j.scitotenv.2014.08.075
|
[100]
|
Walters, E., McClellan, K. and Halden, R.U. (2010) Occurrence and Loss Over Three Years of 72 Pharmaceuticals and Personal Care Products from Biosolids-Soil Mixtures in Outdoor Mesocosms. Water Research, 44, 6011-6020. http://dx.doi.org/10.1016/j.watres.2010.07.051
|
[101]
|
Girardi, C., Greve, J., Lamshöft, M., Fetzer, I., Miltner, A., Schäffer, A., et al. (2011) Biodegradation of Ciprofloxacin in Water and Soil and Its Effects on the Microbial Communities. Journal of Hazardous Materials, 198, 22-30. http://dx.doi.org/10.1016/j.jhazmat.2011.10.004
|
[102]
|
Zhou, X., Chen, C., Yue, L., Sun, Y., Ding, H. and Liu, Y. (2008) Excretion of Enrofloxacin in Pigs and Its Effect on Ecological Environment. Environmental Toxicology and Pharmacology, 26, 272-277. http://dx.doi.org/10.1016/j.etap.2008.04.004
|
[103]
|
Gao, Y., Sun, X., Sun, Z., Zhao, N. and Li, Y. (2008) Toxic Effects of Enrofloxacin on Growth Rate and Catalase Activity in Eisenia fetida. Environmental Toxicology and Pharmacology, 26, 177-180. http://dx.doi.org/10.1016/j.etap.2008.03.004
|
[104]
|
Andrieu, M., Rico, A., Phu, T.M., Huong, D.T.T., Phuong, N.T. and Van den Brink, P.J. (2015) Ecological Risk Assessment of the Antibiotic Enrofloxacin Applied to Pangasius Catfish Farms in the Mekong Delta, Vietnam. Chemosphere, 119, 407-414. http://dx.doi.org/10.1016/j.chemosphere.2014.06.062
|
[105]
|
Rico, A., Dimitrov, M.R., Van Wijngaarden, R.P.A., Satapornvanit, K., Smidt, H. and Van den Brink, P.J. (2014) Effects of the Antibiotic Enrofloxacin on the Ecology of Tropical Eutrophic Freshwater Microcosms. Aquatic Toxicology, 147, 92-104. http://dx.doi.org/10.1016/j.aquatox.2013.12.008
|
[106]
|
Carlsson, G., Patring, J., Kreuger, J., Norrgren, L. and Oskarsson, A. (2013) Toxicity of 15 Veterinary Pharmaceuticals in Zebrafish (Danio rerio) Embryos. Aquatic Toxicology, 126, 30-41. http://dx.doi.org/10.1016/j.aquatox.2012.10.008
|
[107]
|
Beri, S., Sidhu, P.K., Kaur, G., Chandra, M. and Rampal, S. (2014) Comparative Mutant Prevention Concentration and Antibacterial Activity of Fluoroquinolones against Escherichia coli in Diarrheic Buffalo Calves. Journal of Chemotherapy, 27, 312-316.
|
[108]
|
Gebru Awji, E., Tassew, D.D., Lee, J.-S., Lee, S.-J., Choi, M.-J., Reza, M.A., et al. (2012) Comparative Mutant Prevention Concentration and Mechanism of Resistance to Veterinary Fluoroquinolones in Staphylococcus Pseudintermedius. Ve-terinary Dermatology, 23, 376-e69. http://dx.doi.org/10.1111/j.1365-3164.2012.01038.x
|
[109]
|
Berghaus, L.J., Giguère, S. and Guldbech, K. (2013) Mutant Prevention Concentration and Mutant Selection Window for 10 Antimi-crobial Agents against Rhodococcus equi. Veterinary Microbiology, 166, 670-675. http://dx.doi.org/10.1016/j.vetmic.2013.07.006
|
[110]
|
Blondeau, J.M., Borsos, S., Blondeau, L.D., Blondeau, B.J.J. and Hesje, C.E. (2012) Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations of Enrofloxacin, Ceftiofur, Florfenicol, Tilmicosin and Tulathromycin against Bovine Clinical Isolates of Mannheimia haemolytica. Veterinary Microbiology, 160, 85-90. http://dx.doi.org/10.1016/j.vetmic.2012.05.006
|
[111]
|
García Ovando, H., Gorla, N., Luders, C., Poloni, G., Errecalde, C., Prieto, G., et al. (1999) Comparative Pharmacokinetics of Enrofloxacin and Ciprofloxacin in Chickens. Journal of Veterinary Pharmacology and Therapeutics, 22, 209-212. http://dx.doi.org/10.1046/j.1365-2885.1999.00211.x
|
[112]
|
Anadón, A., Martínez-Larrañaga, M.R., Díaz, M.J., Fernández-Cruz, M.L., Martínez, M.A., Frejo, M.T., et al. (1999) Pharmacokinetic Variables and Tissue Residues of Enrofloxacin and Ciprofloxacin in Healthy Pigs. American Journal of Veterinary Research, 60, 1377-1382.
|
[113]
|
Bidgood, T.L. and Papich, M.G. (2005) Plasma and Interstitial Fluid Pharmacokinetics of Enrofloxacin, Its Metabolite Ciprofloxacin, and Marbofloxacin after Oral Administration and a Constant Rate Intravenous Infusion in Dogs. Journal of Veterinary Pharmacology and Therapeutics, 28, 329-341. http://dx.doi.org/10.1111/j.1365-2885.2005.00664.x
|
[114]
|
Bugyei, K., Black, W.D. and McEwen, S. (1999) Pharmacokinetics of Enrofloxacin Given by the Oral, Intravenous and Intramuscular Routes in Broiler Chickens. Canadian Journal of Veterinary Research, 63, 193-200.
|
[115]
|
Messenger, K.M., Papich, M.G. and Blikslager, A.T. (2012) Distribution of Enrofloxacin and Its Active Metabolite, Using an in Vivo Ultrafiltration Sampling Technique after the Injection of Enrofloxacin to Pigs. Journal of Veterinary Pharmacology and Therapeutics, 35, 452-459. http://dx.doi.org/10.1111/j.1365-2885.2011.01338.x
|
[116]
|
Garcia Ovando, H., Gorla, N., Poloni, G., Trotti, N., Prieto, G. and Errecalde, C. (2000) Intravenous Pharmacokinetics of Ciprofloxacin in Goats. International Journal of Antimicrobial Agents, 15, 77-79. http://dx.doi.org/10.1016/S0924-8579(99)00146-6
|
[117]
|
Tang, J., Yang, X., Zheng, Z., Yu, W., Hu, K. and Yu, H. (2006) Pharmacokinetics and the Active Metabolite of Enrofloxacin in Chinese Mitten-Handed Crab (Eriocheir sinensis). Aquaculture, 260, 69-76. http://dx.doi.org/10.1016/j.aquaculture.2006.05.036
|
[118]
|
Suojala, L., Simojoki, H., Mustonen, K., Kaartinen, L. and Pyörälä, S. (2010) Efficacy of Enrofloxacin in the Treatment of Naturally Occurring Acute Clinical Escherichia coli Mastitis. Journal of Dairy Science, 93, 1960-1969. http://dx.doi.org/10.3168/jds.2009-2462
|
[119]
|
Atif, F.A., Khan, M.S., Khan, M.A., Ashraf, M. and Avais, M. (2012) Chemotherapeutic Efficacy of Oxytetracycline, Enrofloxacin and Imidocarb for the Elimination of Persistent Anaplasma marginale Infection in Naturally Infected Sahiwal Cattle. Pakistan Journal of Zoology, 44, 449-456.
|
[120]
|
Facury-Filho, E.J., de Carvalho, A.ú., Ferreira, P.M., Moura, M.F., Apolinário, B.C., Santos, L. de P.H., et al. (2012) Effectiveness of Enrofloxacin for the Treatment of Experimentally-Induced Bovine Anaplasmosis. Revista Brasileira de Parasitologia Veterinária, 21, 32-36. http://dx.doi.org/10.1590/S1984-29612012000100007
|
[121]
|
Thompson, P.N., Van Amstel, S.R. and Henton, M. (1998) The Clinical Efficacy of Enrofloxacin in the Treatment of Experimental Bovine Pneumonic Pasteurellosis. Onderstepoort Journal of Veterinary Research, 65, 105-112.
|
[122]
|
Robb, E.J., Tucker, C.M., Corley, L., Bryson, W.L., Rogers, K.C., Sturgess, K., et al. (2007) Efficacy of Tulathromycin versus Enrofloxacin for Initial Treatment of Naturally Occurring Bovine Respiratory Disease in Feeder Calves. Veterinary Therapeutics, 8, 127-135.
|
[123]
|
Rawiwet, V., Chansiripornchai, P. and Chansiripornchai, N. (2010) Comparison of the Efficacy of Enrofloxacin against Escherichia coli or Pasteurella multocida Infection in Chickens. The Thai Journal of Veterinary Medicine, 40, 297-301.
|
[124]
|
Barbour, E.K., Hamadeh, S., Talhouk, R., Sakr, W. and Darwish, R. (1998) Evaluation of an Enroflox-acin-Treatment Program against Mycoplasma gallisepticum Infection in Broilers. Preventive Veterinary Medicine, 35, 91-99. http://dx.doi.org/10.1016/S0167-5877(98)00055-5
|
[125]
|
Randall, L.P., Cooles, S.W., Coldham, N.C., Stapleton, K.S., Piddock, L.J.V. and Woodward, M.J. (2006) Modification of Enrofloxacin Treatment Regimens for Poultry Experimentally Infected with Salmonella enterica Serovar Typhimurium DT104 To Minimize Selection of Resistance. Antimicrobial Agents and Chemotherapy, 50, 4030-4037. http://dx.doi.org/10.1128/AAC.00525-06
|
[126]
|
Huff, W.E., Huff, G.R., Rath, N.C., Balog, J.M. and Donoghue, A.M. (2004) Therapeutic Efficacy of Bacteriophage and Baytril (Enrofloxacin) Individually and in Combination to Treat Colibacillosis in Broilers. Poultry Science, 83, 1944-1947. http://dx.doi.org/10.1093/ps/83.12.1944
|
[127]
|
Garmyn, A., Martel, A., Froyman, R., Nauwynck, H., Duchateau, L., Haesebrouck, F., et al. (2009) Efficacy of Four Enrofloxacin Treatment Regimens against Experimental Infection in Turkey Poults with Avian Pneumovirus and Ornithobacterium rhinotracheale. Avian Pathology, 38, 287-292. http://dx.doi.org/10.1080/03079450903055413
|
[128]
|
Neer, T.M., Eddlestone, S.M., Gaunt, S.D. and Corstvet, R.E. (1999) Efficacy of Enrofloxacin for the Treatment of Experimentally Induced Ehrlichia Canis Infection. Journal of Veterinary Internal Medicine, 13, 501-504. http://dx.doi.org/10.1111/j.1939-1676.1999.tb01470.x
|
[129]
|
Reddy, S., Kumari, K.N., Rao, V.V., Rayulu, V.C. and Sivajothi, S. (2014) Efficacy of Enrofloxacin in the Treatment of Recurrent Pyoderma in Dogs. Journal of Advanced Veterinary and Animal Research, 4, 108-112.
|
[130]
|
Wanke, M.M., Delpino, M.V. and Baldi, P.C. (2006) Use of Enrofloxacin in the Treatment of Canine Brucellosis in a Dog Kennel (Clinical Trial). Theriogenology, 66, 1573-1578. http://dx.doi.org/10.1016/j.theriogenology.2006.01.034
|
[131]
|
Kordick, D.L., Papich, M.G. and Breitschwerdt, E.B. (1997) Efficacy of Enrofloxacin or Doxycycline for Treatment of Bartonella henselae or Bartonella clarridgeiae Infection in Cats. Antimicrobial Agents and Chemotherapy, 41, 2448-2455.
|
[132]
|
Gerhardt, N., Schulz, B.S., Werckenthin, C. and Hartmann, K. (2006) Pharmacokinetics of Enrofloxacin and Its Efficacy in Comparison with Doxycycline in the Treatment of Chlamydophila felis Infection in Cats with Conjunctivitis. Veterinary Record, 159, 591-594. http://dx.doi.org/10.1136/vr.159.18.591
|
[133]
|
Slate, A.R., Bandyopadhyay, S., Francis, K.P., Papich, M.G., Karolewski, B., Hod, E.A., et al. (2014) Efficacy of Enrofloxacin in a Mouse Model of Sepsis. Journal of the American Association for Laboratory Animal Science, 53, 381-386.
|
[134]
|
Barbosa, B.F., Gomes, A.O., Ferro, E.A.V., Napolitano, D.R., Mineo, J.R. and Silva, N.M. (2012) Enrofloxacin Is Able to Control Toxoplasma gondii Infection in Both in Vitro and in Vivo Experimental Models. Veterinary Parasitology, 187, 44-52. http://dx.doi.org/10.1016/j.vetpar.2011.12.039
|
[135]
|
Mahler, M., Stunkel, S., Ziegowski, C. and Kunstyr, I. (1995) Inefficacy of Enrofloxacin in the Elimination of Pasteurella multocida in Rabbits. Laboratory Animals, 29, 192-199. http://dx.doi.org/10.1258/002367795780740195
|
[136]
|
Roque, A. and Gomez-Gil, B. (2003) Therapeutic Effects of Enrofloxacin in an Experimental Infection with a Luminescent Vibrio harveyi in Artemia franciscana Kellog 1906. Aquaculture, 220, 37-42. http://dx.doi.org/10.1016/S0044-8486(02)00272-7
|